The Official Magazine of ISPE September-October 2016 | Volume 36, Number 5 Lou Schmukler of BMS on Creating Supply Chain Excellence How to Fight a Bully: An Interview with Nicole Pierson Meet Your 2016-2017 Board of Directors Quarterly Report: BIOTECHNOLOGY www.PharmaceuticalEngineering.org Pharmaceutical Engineering | September-October 2016 | 1 WHY WE DO IT CLEAN AIR MATTERS camfilapc.com/cleanairmatters Farr Gold Series® Camtain Dust Collector Quad Pulse Package Dust Collector Dust, Mist and Fume Collectors AIR POLLUTION CONTROL www.camfilapc.com • e-mail:
[email protected] • 855-405-2271 CHANGE IS OPPORTUNITY Some see change as a problem; we see change as an opportunity. Adapting to the evolving trends and ever- changing regulations in the life sciences industry is what we’re known for. We’re driven to find the right solution to the most technically challenging problems. And we’re satisfied only when we’ve produced results that make you successful. crbusa.com THE RELENTLESS PURSUIT OF SUCCESS. YOURS .™ Biological Animal Health OSD Blood Fractionation Fill/Finish Oligonucleo/Peptides Vaccines Medical Devices API’s Nutraceuticals Engineering | Architecture | Construction | Consulting Editor’s Voice A First Time for Everything My introduction to the world of biopharma occurred in June 2015 as I listened to Andy Skibo, then Chair of ISPE’s Board, deliver his “Biologics Supply Chain Risks” keynote address at the ISPE/FDA/PQRI Editorial Board Quality Manufacturing Conference in Washington, DC. He emphasized the potential effect of supply Editor in chief: Anna Maria di Giorgio chain risk on biologics, which are projected to account for 80% of the pipeline and 70% of sales revenue Managing editor: Amy Loerch by 2020—just three short years away.